v3.8.0.1
Condensed Consolidated Statement of Changes in Equity (Unaudited) - 9 months ended Dec. 31, 2017 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Total
Balance at Mar. 31, 2017 $ 1,629,458 $ 150,889,613 $ (148,223,822) $ (2,308,672) $ 2,479,512 $ 4,466,089
Balance, shares at Mar. 31, 2017 162,945,805          
Net loss (482,498) 562,505 80,007
Foreign currency translation adjustment 182,033 182,033
Exercise of common stock options $ 2,692 202,076 $ 204,768
Exercise of common stock options, shares 269,200         269,200
Restricted share grants $ 10,920 (10,920)
Restricted share grants, shares 1,092,000          
Conversion of 5% Convertible Notes to common stock $ 10,313 917,854 $ 928,167
Conversion of 5% Convertible Notes to common stock, shares 1,031,297         1,031,297
Stock-based compensation 1,484,306 $ 1,484,306
Balance at Dec. 31, 2017 $ 1,653,383 $ 153,482,929 $ (148,706,320) $ (2,126,639) $ 3,042,017 $ 7,345,370
Balance, shares at Dec. 31, 2017 165,338,302